UBS Group’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,165
| Closed | -$47K | – | 8618 |
|
|
2020
Q4 | $47K | Buy |
4,165
+3,045
| +272% | +$34.4K | ﹤0.01% | 5257 |
|
|
2020
Q3 | $7K | Sell |
1,120
-4,201
| -79% | -$26.3K | ﹤0.01% | 6298 |
|
|
2020
Q2 | $35K | Sell |
5,321
-6,633
| -55% | -$43.6K | ﹤0.01% | 5340 |
|
|
2020
Q1 | $79K | Sell |
11,954
-12,211
| -51% | -$80.7K | ﹤0.01% | 4615 |
|
|
2019
Q4 | $251K | Buy |
24,165
+9,909
| +70% | +$103K | ﹤0.01% | 4449 |
|
|
2019
Q3 | $90K | Buy |
14,256
+7,934
| +125% | +$50.1K | ﹤0.01% | 4909 |
|
|
2019
Q2 | $47K | Buy |
6,322
+4,422
| +233% | +$32.9K | ﹤0.01% | 5125 |
|
|
2019
Q1 | $12K | Sell |
1,900
-5,622
| -75% | -$35.5K | ﹤0.01% | 5877 |
|
|
2018
Q4 | $87K | Buy |
7,522
+411
| +6% | +$4.75K | ﹤0.01% | 4766 |
|
|
2018
Q3 | $154K | Buy |
7,111
+3,273
| +85% | +$70.9K | ﹤0.01% | 4403 |
|
|
2018
Q2 | $60K | Buy |
3,838
+3,468
| +937% | +$54.2K | ﹤0.01% | 4957 |
|
|
2018
Q1 | $7K | Sell |
370
-524
| -59% | -$9.91K | ﹤0.01% | 6219 |
|
|
2017
Q4 | $16K | Buy |
894
+566
| +173% | +$10.1K | ﹤0.01% | 5773 |
|
|
2017
Q3 | $5K | Sell |
328
-1,343
| -80% | -$20.5K | ﹤0.01% | 6336 |
|
|
2017
Q2 | $31K | Sell |
1,671
-707
| -30% | -$13.1K | ﹤0.01% | 5071 |
|
|
2017
Q1 | $40K | Buy |
2,378
+222
| +10% | +$3.73K | ﹤0.01% | 4789 |
|
|
2016
Q4 | $46K | Buy |
+2,156
| New | +$46K | ﹤0.01% | 4979 |
|
|
2016
Q3 | – | Sell |
-1,343
| Closed | -$39K | – | 6946 |
|
|
2016
Q2 | $39K | Buy |
+1,343
| New | +$39K | ﹤0.01% | 4858 |
|